Oral administration of adenosine analogs
US6174873A · kind A · utility
24Cited by
19References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 4, 1998 |
| Grant date | Jan 16, 2001 |
| Priority date | — |
| Expiry date | Nov 4, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compositions including an adenosine analog, wherein the composition comprises a dosage form suitable for oral (co)administration. Also disclosed are compositions including adenosine analogs, wherein the composition is in a dosage form including a pill, capsule, lozenge, or tablet, and compositions including adenosine analogs, wherein the composition is in a dosage form comprising a liquid. Additionally disclosed are methods of administering the inventive composition, and kits including the inventive compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.